Data / Form D filings / Aurora Pharmaceutical, LLC
Aurora Pharmaceutical, LLC: Form D filings
Aurora Pharmaceutical, LLC, a pharmaceuticals company in Northfield, MN, filed 4 Form D notices with the SEC between 2010 and 2015. The latest, on May 27, 2015, reports $2.4 million sold of a $2.4 million offering to 3 investors.
Find out what Aurora Pharmaceutical, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1196 S. HIGHWAY 3, Northfield, MN, 55057
- Phone
- (507) 650-7207
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Minnesota
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1486301
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 27, 2015 | New notice | $2,412,000 | $2,412,000 | $0 | 3 | May 18, 2015 | sec.gov |
| Nov 23, 2011 | Amendment | $7,000,000 | $5,045,000 | $1,955,000 | 42 | May 2, 2010 | sec.gov |
| Mar 7, 2011 | Amendment | $5,000,000 | $3,060,000 | $1,940,000 | 33 | May 2, 2010 | sec.gov |
| Mar 23, 2010 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MARK G. WERNER | Executive Officer, Director | |
| MICHAEL A. STROBEL | Executive Officer, Director |
Every Form D from the week of May 25, 2015 · All recent filings in Minnesota · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aurora Pharmaceutical, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.